Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, June 7, 2023
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
[ Wed, Jun 07th 2023
] - WOPRAI
Bradley Canino Maintained (ZNTL) at Strong Buy with Increased Target to $50 on, Jun 7th, 2023
Bradley Canino of Stifel, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Increased Target from $45 to $50 on, Jun 7th, 2023.
Bradley has made no other calls on ZNTL in the last 4 months.
There are 3 other peers that have a rating on ZNTL. Out of the 3 peers that are also analyzing ZNTL, 0 agree with Bradley's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Bradley
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $55 on, Friday, May 26th, 2023
- Matthew Biegler of "Oppenheimer" Reiterated at Buy and Held Target at $50 on, Friday, May 26th, 2023
- Biren Amin of "Jefferies" Maintained at Strong Buy with Decreased Target to $70 on, Friday, May 19th, 2023
